Nephrocare Health Services IPO Enters Day Two — Check Subscription Details, GMP And More
Bloomberg • 12/11/2025 • Last cited 12/14/2025
Summary
Nephrocare Health Services' IPO has entered its second day, with details on subscription rates and the grey market premium (GMP) available for investors. Bloomberg reports on the ongoing interest and market response to the offering.
Lindy Score Breakdown
35
Age (0-35)
36 days
4
Velocity (0-40)
1 source (low traction)
8
Tier (0-10)
Bloomberg
0
Breadth (0-15)
1 unique
Total Score47/100
Related Story Timeline
- 2025-12-10SEBI Relaxes Re-KYC Process For NRIs; Removes Physical Presence Clause (Bloomberg)
- 2025-12-11Nephrocare Health Services IPO Enters Day Two — Check Subscription Details, GMP And More (current)
- 2025-12-12IndiGo Denies Media Reports Of SEBI Enquiry Against Parent Company (Bloomberg)
Score BreakdownRisk 35
Source Reputation: Moderate trust (8/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 36 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Anti-Lindy Similar stories
Bharat Coking Coal IPO Allotment: Steps To Check Status Online, Latest GMP And Other Key Details
Bloomberg • 2 days ago
Kotak Isn't Hitting The Brakes On TVS Motor; GST Cuts, EVs, Exports Add Fuel To The Tank — Details Inside
Bloomberg • 2 days ago
Apple iPhone 18 Display Specs Tipped; Pro Models To Get Under-Display Face ID
Bloomberg • 1 day ago
Explained: US Credit Card Competition Bill And How It Can Impact Visa, Mastercard
Bloomberg • 2 days ago
Ola Electric Announces Expansion Of 4680 Bharat Cell Platform
Bloomberg • 1 day ago
IOC, BPCL Announce Second Oil Discovery In Abu Dhabi's Onshore Block, Boosting India's Energy Security
Bloomberg • 1 day ago
India Open Badminton: PV Sindhu Out, Kidambi Srikanth Advances To 2nd Round
Bloomberg • 1 day ago
Samsung Galaxy S26 Ultra: Top 7 Upgrades To Look Out For
Bloomberg • 2 days ago
Bank Of Maharashtra Shares Pare Gains After Hitting 17-Month High After Q3 Results
Bloomberg • 2 days ago
Not Vodafone Idea, Indus Towers Is The Stock To Benefit Most From Vi's Revival Play, Says Brokerage
Bloomberg • 2 days ago